Clinical Trials Directory

Trials / Completed

CompletedNCT05727735

Signia Stapler Versus Vessel Sealer Extend Energy Device With SureForm Stapling in Robotic-Assisted Segmentectomy

The Feasibility of Assessing Economic Costs of the Signia Stapler Versus Vessel Sealer Extend Energy Device With SureForm Stapling in Robotic-Assisted Segmentectomy for Lung Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
56 (actual)
Sponsor
St. Joseph's Healthcare Hamilton · Academic / Other
Sex
All
Age
18 Years – 120 Years
Healthy volunteers
Not accepted

Summary

Robotic-assisted thoracoscopic surgery (RTS) segmentectomy is safe and effective for patients with early-stage non-small cell lung cancer (NSCLC). In RTS-segmentectomy, dissection and sealing procedures are performed by either staplers or energy devices. Staplers, the current standard of care, have been associated with higher operating costs compared to energy devices for open lobectomy, RTS lobectomy and minimally invasive segmentectomy. However, there is a lack of prospective research evaluating the costs of the two methods for lung dissection and vessel sealing in RTS-segmentectomy. This prospective trial seeks to determine whether it is feasible to conduct a randomized controlled trial evaluating the costs of the Signia stapler versus Vessel Sealer Extend energy device in RTS-segmentectomy for NSCLC. If this trial is feasible, we will be able to conduct a full-scale trial to compare costs and health outcomes, providing an economic evaluation that will inform hospital decision makers and clinicians in Canada.

Conditions

Interventions

TypeNameDescription
DEVICEMedtronic Signia StaplerThe Signia Stapler is a powered stapler that can be used for tissue dissection and vessel sealing during surgery.
DRUGDa Vinci Vessel Sealer Extend Energy Device with SureForm StaplingThe Vessel Sealer Extend Energy Device is integrated with the da Vinci system and uses bipolar energy technology to facilitate tissue dissection and vessel sealing.

Timeline

Start date
2023-04-14
Primary completion
2024-04-30
Completion
2024-04-30
First posted
2023-02-14
Last updated
2024-07-31

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05727735. Inclusion in this directory is not an endorsement.